Page tree
Skip to end of metadata
Go to start of metadata


Date

20221001

Document Version

1.0

Release Status

PRODUCTION

© 2023 International Health Terminology Standards Development Organisation.  All rights reserved.  SNOMED CT® was originally created by the College of American Pathologists.

This document forms part of the SNOMED CT® New Zealand Extension release distributed by International Health Terminology Standards Development Organisation, trading as SNOMED International, and is subject to the SNOMED CT® Affiliate License, details of which may be found at https://www.snomed.org/snomed-ct/get-snomed

No part of this document may be reproduced or transmitted in any form or by any means, or stored in any kind of retrieval system, except by an Affiliate of SNOMED International in accordance with the SNOMED CT® Affiliate License. Any modification of this document (including without limitation the removal or modification of this notice) is prohibited without the express written permission of SNOMED International.

Any copy of this document that is not obtained directly from SNOMED International [or a Member of SNOMED International] is not controlled by SNOMED International, and may have been modified and may be out of date. Any recipient of this document who has received it by other means is encouraged to obtain a copy directly from SNOMED International [or a Member of SNOMED International. Details of the Members of SNOMED International may be found at http://www.snomed.org/members/].








Page At A Glance

Introduction

Te Whatu Ora - Health New Zealand works with health agencies and their industry partners to develop SNOMED CT® reference sets, maps, language reference sets and other content for digital health solutions in Aotearoa New Zealand.

The SNOMED CT New Zealand Extension packages these components for release every April and October, to be used with the latest designated SNOMED CT International Edition release.

The same content can be viewed online using the SNOMED CT browser and accessed via our standard SNOMED CT terminology service

We welcome your feedback and participation. For more information about SNOMED CT implementation in New Zealand, see our website or join our standards channel at forum.hinz.org.nz.

Background

This document provides a summarized description of the content changes included in the October 2022 production release of the SNOMED CT NZ Extension package.

It will also include technical notes detailing any known issues which have been identified. These are content or technical issues where the root cause is understood, and the fix has been discussed and agreed, but has yet to be implemented.

This SNOMED CT NZ Extension package is dependent upon, and should therefore be consumed in conjunction with the SNOMED CT July 2022 International Edition release.

Content development activity

Summary

Content from the SNOMED CT July 2022 International Edition release has been incremented, using additional components for use in New Zealand. 

The October 2022 release includes updates to the previously released content in the SNOMED CT NZ Extension release and introduces some new content.

New and updated content

Concept statistics

The SNOMED NZ National Release Centre promoted 25 new concepts into the SNOMED CT July 2022 International Edition release.

Table 1. New concepts in the SNOMED International July 2022 release by hierarchy

Total number of concepts25
Body structure (body structure)2
Procedure (procedure)9
Qualifier value (qualifier value)10
Situation with explicit context (situation)4

 Refer to Appendix 1, Table 1.1 to view the 25 new concepts.


There are 213 new concepts in this release.

Table 2. New concepts in the SNOMED CT NZ Extension October 2022 release by hierarchy

Total number of concepts

213

Clinical finding (finding)

18

Disease (disorder)11
SNOMED CT Model Component (metadata)3

Observable entity (observable entity)

3

Procedure (procedure)17

Qualifier value (qualifier value)

71

Regimes and therapies (regime/therapy)51

Situation with explicit context (situation)

34

Social context (social concept)5

Refer to Appendix 1, Table 2.1 to view the 213 new concepts.

Description statistics 

The SNOMED NZ NRC promoted 0 new descriptions to the SNOMED CT International Edition July 2022 release.

Table 3. New descriptions in the SNOMED International July 2022 release 

SNOMED CT Concept ID (SCTID)

SNOMED CT Fully Specified Name (FSN)

New description

-

-

-


There are 7 new descriptions in this release.

Table 4 New descriptions in the SNOMED CT NZ Extension October 2022 release

SNOMED CT Concept ID (SCTID)SNOMED CT Fully Specified Name (FSN)New description
91489000

Acute vascular insufficiency of intestine (disorder)

Acute mesenteric ischaemia

192759008

Cerebral venous sinus thrombosis (disorder)

CVST-Cerebral venouse sinus thrombosis

43185009

Mild dysplasia (morphologic abnormality)

Low grade dysplasia

55237006

Severe dysplasia (morphologic abnormality)

High grade dysplasia

385658003

Done (qualifier value)

Completed

700232004General medical service (qualifier value)General medicine service
310078000Medical microbiology service (qualifier value)Microbiology service

Reference sets

There are 59 reference sets in the October 2022 release.

For more information about New Zealand reference sets, please visit our website.

The New Zealand reference set list is available in Appendix 1, table 3.1.

Language reference sets

Language reference sets are created to define preferred terms and synonyms associated with each concept. There are three language reference sets in the October 2022 release.

Language Reference Set Name

SNOMED CT Concept ID (SCTID)

Members

Maori [International Organization for Standardization 639-1 code mi] language reference set (foundation metadata concept)

291000210106


 157

New Zealand English language reference set (foundation metadata concept)

271000210107


1155061

New Zealand English patient friendly terms language reference set (foundation metadata concept)

281000210109


157

Maps

Five maps between SNOMED CT and other code systems are contained in the October 2022 release.

Map Name

SNOMED CT Concept ID (SCTID)

Members

ACC translation table map (foundation metadata concept)

401000210101

12795

MSD translation table map (foundation metadata concept)

411000210104

58134

NZMT medicinal product to SNOMED CT map (foundation metadata concept)

311000210107

2125

READ v2 to SNOMED CT map (foundation metadata concept)

31000210106

88273

SNOMED CT to READ v2 map (foundation metadata concept)

41000210103

66966

Technical notes

Known Issues 

Known Issues are content or technical issues where the root cause is understood, and the resolution has been discussed and agreed but has yet to be implemented.  This can be due to a number of reasons, from lack of capacity within the current editing cycle, to the risk of impact to the stability of SNOMED CT if the fix were to be deployed at that stage in the Product lifecycle.  

The following known issues were identified, and agreed to be resolved in the next editing cycle:

Key Summary Description P
Loading...
Refresh

Notice of changes to the International Edition Release Schedule

As you may already know SNOMED International have transitioned to a monthly delivery schedule for the International Edition of SNOMED CT. The move towards more frequent releases of SNOMED CT realizes several benefits, including:

  • The potential to be able to get content changes into the terminology in a shorter time frame.
  • The fostering of better interoperability, as a result of entities being able to consume release content that is more aligned with other organizations.
  • The prevention of circular dependencies that occur in longer projects, due to the move towards smaller, more manageable authoring projects.
  • More automated validation services, as a result of the inherent removal of the Alpha/Beta stages in the Release cycle.

Whilst most users will continue unaffected (as they can simply continue to download the releases every 6 months as always), this transition will necessarily involve a few changes to process/packages:

  • Delta files have been removed from both International and Managed Service release packages, including the New Zealand Extension.  A Delta Generation service will be provided for those who need it. The Delta Generation Tool allows users to create their own Delta between two fixed release dates - you can find it here:
  • The ICD-O/ICD-10 Maps will continue to be published in each Monthly International Edition release package (in line with that month's content) for the foreseeable future, unless we experience issues with the new process in Production, and they need to be removed at a later date.

The first monthly Release of the SNOMED CT International Edition was published on the 28th February 2022 with the Delta files having been removed, and therefore they will be removed from the New Zealand Extension from the October 2022 Release onwards.

Please note - While the SNOMED CT International Edition is moving to monthly releases, the New Zealand Extension of SNOMED CT will remain on the current bi-annual release schedule of April and October for 2022.

Appendix 1

Table 1.1. New concepts in SNOMED CT International Edition July 2022 release

SNOMED CT Concept ID

(SCTID)

SNOMED CT Fully Specified Name (FSN)

Semantic tag

1217007000Structure of left vastus lateralis muscle (body structure)Body structure
1217006009Structure of right vastus lateralis muscle (body structure)Body structure
1196929001Computed tomography dual phase study of abdomen with contrast (procedure)Procedure
1196930006 Computed tomography dual phase study of kidney (procedure)Procedure
1196925007 Computed tomography of head, neck and thorax with contrast (procedure)Procedure
1196926008 Computed tomography triple phase study of pancreas (procedure)

Procedure

1196932003 Computed tomography venography of vein of upper limb with contrast (procedure)Procedure
1204278004Cryoablation of lesion using fluoroscopic guidance (procedure)Procedure
1204075006 Discography of cervical spine using fluoroscopic guidance (procedure)Procedure
1204074005 Discography of thoracic spine using fluoroscopic guidance (procedure)Procedure
1197441007 Ultrasonography of kidney with contrast (procedure)Procedure
1230045006 Cardiac diagnostic service (qualifier value)Qualifier value
1230044005 Cardiac specialist nursing service (qualifier value)Qualifier value
1230046007 Cervical cancer screening service (qualifier value)Qualifier value
1231391000 Colonoscopy service (qualifier value)Qualifier value
1234796008 Community nursing service (qualifier value)Qualifier value
1231390004 Hand therapy service (qualifier value)Qualifier value
1231392007 Pediatric orthopedic service (qualifier value)Qualifier value
1231394008 Pediatric urology service (qualifier value)Qualifier value
1231786003 Refugee healthcare service (qualifier value)Qualifier value
1231393002 Spirometry service (qualifier value)Qualifier value
1234920002 Diphtheria and acellular pertussis and inactivated poliomyelitis and tetanus vaccination given (situation)Situation
1234918000 Haemophilus influenza type B vaccination given (situation)Situation
1234922005 Varicella-zoster vaccination for chicken pox given (situation)Situation
1234919008 Varicella-zoster vaccination given (situation)Situation


Table 2.1. New concepts in the SNOMED CT NZ Extension October 2022 release

SNOMED CT Concept ID

(SCTID)

SNOMED CT Fully Specified Name (FSN)

Semantic tag

181821000210104Metastasis from biliary tract (disorder)

Disorder

192061000210109Metastasis from gastrointestinal stromal tumor (disorder)

Disorder

191621000210101Metastasis from malignant neoplasm of gallbladder and biliary tract (disorder)Disorder
191681000210100Metastasis from malignant neoplasm of nasopharynx (disorder)Disorder
191671000210102Metastasis from malignant tumor of salivary gland (disorder)Disorder
181811000210109Metastasis from merkel cell carcinoma (disorder)Disorder
181781000210106Metastasis from mesothelioma (disorder)Disorder
181771000210109Metastasis from non-small cell lung cancer (disorder)Disorder
181791000210108Metastasis from small cell carcinoma (disorder)Disorder
181801000210107Primary malignant melanoma of skin (disorder)Disorder
181841000210105Primary of malignant neoplasm of gallbladder and biliary tract (disorder)Disorder
161901000210103Abnormal pattern finding (finding)Finding
161721000210108Eligible for influenza immunization programme due to medical condition (finding)

Finding

161751000210104Eligible for influenza immunization programme due to pregnancy (finding)Finding
161761000210101Eligible for influenza immunization programme for Māori and/or Pacific person aged 55 to 64 years of age (finding)Finding
161771000210107Eligible for influenza immunization programme for people 65 years of age and older (finding)Finding
161731000210105Eligible for inluenza immunization programme for child four years of age or under due to history of hospitalization with respiratory condition (finding)Finding
161681000210102Eligible for publicly funded health service (finding)Finding
201591000210104Immunity confirmed by documented serology (finding)Finding
161871000210103Intact nuclear expression (finding)Finding
161881000210101Loss of nuclear expression (finding)Finding
161701000210100Meets eligibility criteria for publicly funded health service (finding)Finding
161711000210103Meets eligibility criteria for vaccination programme (finding)Finding
161691000210100Not eligible for publicly funded health service (finding)Finding
161821000210102Surgical margin involved by adenoma (finding)Finding
161841000210108Surgical margin involved by adenoma with high grade dysplasia (finding)Finding
161831000210100Surgical margin involved by adenoma with low grade dysplasia (finding)Finding
161851000210106Surgical margin involved by sessile serrated lesion (finding)Finding
161861000210109Surgical margin not involved by adenoma with dysplasia (finding)Finding
192081000210101New Zealand priority score reference set (foundation metadata concept)Foundation metadata concept
192071000210103New Zealand referral status reference set (foundation metadata concept)Foundation metadata concept
192091000210104New Zealand suspicion of cancer reference set (foundation metadata concept)Foundation metadata concept
161671000210104Eligibility for influenza immunization programme (observable entity)Observable entity
161661000210105 Eligibility for publicly funded health service (observable entity)Observable entity
161741000210102Eligibility for vaccination programme (observable entity)Observable entity
191781000210107Administration of prophylactic anticonvulsant (procedure)Procedure
181651000210109Prevention of diphtheria, tetanus and pertussis (procedure)Procedure
181641000210106Prevention of diphtheria, tetanus, pertussis and polio (procedure)Procedure
181631000210103Prevention of diphtheria, tetanus, pertussis, polio, hepatitis B and Haemophilus influenzae type b (procedure)Procedure
181621000210100Prevention of Haemophilus influenzae type b infection (procedure)Procedure
181611000210105Prevention of herpes zoster (procedure)Procedure
181601000210108Prevention of human papillomavirus infection (procedure)Procedure
181561000210108Prevention of influenza (procedure)Procedure
171841000210100Prevention of measles, mumps and rubella (procedure)Procedure
181581000210100Prevention of pneumococcal disease (procedure)Procedure
181571000210102Prevention of Rotavirus (procedure)Procedure
181551000210105Prevention of severe acute respiratory syndrome coronavirus 2 (procedure)Procedure
181591000210103Prevention of varicella (procedure)Procedure
171661000210103Provision for longer appointment time (procedure)Procedure
171671000210109Provision for New Zealand sign language interpreter service (procedure)Procedure
171651000210101Provision for wheelchair access (procedure)Procedure
171681000210106Provision of spacious environment for mobility (procedure)Procedure
191631000210104Abuse and violence service (qualifier value)Qualifier value 
171761000210107Abuse prevention serviceQualifier value 
171741000210106Acupuncture serviceQualifier value 
161961000210104Aged residential care hospital level respite service (qualifier value)Qualifier value 
161931000210108Aged residential care hospital level service (qualifier value)Qualifier value 
161971000210105Aged residential care respite service (qualifier value)Qualifier value 
161911000210101Aged residential care service (qualifier value)Qualifier value 
171621000210105Anger management service (qualifier value)Qualifier value 
141541000210102Asian support service (qualifier value)Qualifier value 
181691000210102Auditory processing disorder service (qualifier value)Qualifier value 
171701000210108Cancer support service (qualifier value)Qualifier value 
192011000210107Chinese medicine service (qualifier value)Qualifier value 
192111000210108Community care coordination service (qualifier value)Qualifier value 
171811000210101Community patient support service (qualifier value)Qualifier value 
181831000210102Disability supported accommodation service (qualifier value)Qualifier value 
171691000210108Driving and vehicle adaptation assesment service (qualifier value)Qualifier value 
171591000210107Ear nurse specialist service (qualifier value)Qualifier value 
141581000210109Early pregnancy assessment service (qualifier value)Qualifier value 
151551000210102Eating disorder service (qualifier value)Qualifier value 
171611000210100Elder abuse response service (qualifier value)Qualifier value 
191601000210109Expired (qualifier value)Qualifier value 
192101000210106Family violence intervention service (qualifier value)Qualifier value 
141521000210108Family whānau support services (qualifier value)Qualifier value 
161561000210106High to moderate emetic risk (qualifier value)Qualifier value 
141531000210105Home care support service (qualifier value)Qualifier value 
192051000210106Hospital administrative service (qualifier value)Qualifier value 
24081000087105Human immunodeficiency virus nurse practitioner service (qualifier value)Qualifier value 
181701000210102Immigration medical service (qualifier value)Qualifier value 
171791000210102Immunization service (qualifier value)Qualifier value 
181751000210101Infusion service (qualifier value)Qualifier value 
141561000210101Intellectual disability residential care respite service (qualifier value)Qualifier value 
171641000210104Kaupapa Māori service (qualifier value)Qualifier value 
181761000210103Lesbian, Gay, Bisexual,Transgender, Queer, Intersexed and Asexual support service (qualifier value)Qualifier value 
161551000210108Low to minimal emetic risk (qualifier value)Qualifier value 
171771000210101Mobility equipment support service (qualifier value)Qualifier value 
191571000210103Not determined - pending test (qualifier value)Qualifier value 
191581000210101Not prioritised (qualifier value)Qualifier value 
192021000210102Occupational medicine service (qualifier value)Qualifier value 
171751000210109Osteopathy serviceQualifier value 
192041000210108Outreach service (qualifier value)Qualifier value 
91581000210106Pacific Island people service (qualifier value)Qualifier value 
171821000210106Parenting support serviceQualifier value 
171711000210105Patient transport service (qualifier value)Qualifier value 
151561000210104Pediatric vision and hearing service (qualifier value)Qualifier value 
171781000210104Pediatric vision serviceQualifier value 
191611000210106Pending (qualifier value)Qualifier value 
141571000210107Physical disability residential care respite service (qualifier value)Qualifier value 
171801000210103Physical exercise service (qualifier value)Qualifier value 
171581000210105Pre-admission assessment service (qualifier value)Qualifier value 
191691000210103Priority not stated (qualifier value)Qualifier value 
161941000210100Psychogeriatric residential care hospital level respite service (qualifier value)Qualifier value 
161951000210102Psychogeriatric residential care respite service (qualifier value)Qualifier value 
161921000210106Psychogeriatric residential care service (qualifier value)Qualifier value 
171631000210107Refuge service (qualifier value)Qualifier value 
191591000210104Rejected (qualifier value)Qualifier value 
192121000210103Rural hospital service (qualifier value)Qualifier value 
181731000210107School health service (qualifier value)Qualifier value 
181711000210100Screening service (qualifier value)Qualifier value 
191561000210109Semi urgent (qualifier value)Qualifier value 
151531000210108Sexual abuse medicine service (qualifier value)Qualifier value 
151521000210106Sexual harm service (qualifier value)Qualifier value 
181721000210105Specimen collection service (qualifier value)Qualifier value 
181741000210104Tertiary education student health service (qualifier value)Qualifier value 
161891000210104Test failed (qualifier value)Qualifier value 
191661000210108Transferred (qualifier value)Qualifier value 
171831000210108Transfusion service (qualifier value)Qualifier value 
171721000210100Transport service (qualifier value)Qualifier value 
141591000210106Urgent care medical service (qualifier value)Qualifier value 
191641000210107Violence prevention service (qualifier value)Qualifier value 
192031000210100Well child service (qualifier value)Qualifier value 
141511000210103Youth support service (qualifier value)Qualifier value 
59301000210102Breast metastatic - CMF classical IV cyclophosphamide, methotrexate and fluorouracil chemotherapy regimen (regime/therapy)Regime/therapy
59151000210103Breast metastatic - docetaxel and trastuzumab triweekly chemotherapy regimen (regime/therapy)Regime/therapy
59131000210109Breast metastatic AC doxorubicin and cyclophosphamide chemotherapy regimen (regime/therapy)Regime/therapy
59191000210105Breast metastatic capecitabine 1000 and trastuzumab triweekly chemotherapy regimen (regime/therapy)Regime/therapy
59181000210108Breast metastatic docetaxel triweekly chemotherapy regimen (regime/therapy)Regime/therapy
59171000210106Breast metastatic docetaxel, pertuzumab and trastuzumab chemotherapy regimen (regime/therapy)Regime/therapy
59161000210100Breast non-metastatic AC doxorubicin and cyclophosphamide triweekly followed by paclitaxel weekly chemotherapy regimen (regime/therapy)Regime/therapy
59121000210107Breast non-metastatic AC TH doxorubicin and cyclophosphamide triweekly followed by docetaxel and trastuzumab triweekly chemotherapy regimen (regime/therapy)Regime/therapy
59311000210100Breast non-metastatic CMF classical IV cyclophosphamide, methotrexae and fluorouracil chemotherapy regimen (regime/therapy)Regime/therapy
59141000210101Breast non-metastatic FEC-D75 fluorouracil, epirubicin and cyclophosphamide followed by docetaxel chemotherapy regimen (regime/therapy)Regime/therapy
211601000210107Childhood immunization program (regime/therapy)Regime/therapy
191831000210103Cytomegalovirus infection monitoring (regime/therapy)Regime/therapy
59381000210106Head and neck nasopharyngeal metastatic gemcitabine and carboplatin chemotherapy regimen (regime/therapy)Regime/therapy
59361000210103Head and neck nasopharyngeal metastatic gemcitabine and cisplatin chemotherapy regimen (regime/therapy)Regime/therapy
59441000210109Head and neck nasopharyngeal non-metastatic cisplatin triweekly chemoradiation followed by cisplatin and fluorouracil chemotherapy regimen (regime/therapy)Regime/therapy
59331000210107Head and neck nasopharyngeal non-metastatic cisplatin weekly chemoradiation (regime/therapy)Regime/therapy
59431000210101Head and neck salivary gland metastatic CAP cyclophosphamide, doxorubicin and cisplatin chemotherapy regimen (regime/therapy)Regime/therapy
59461000210105Head and neck salivary gland metastatic cisplatin and vinorelbine intavenous chemotherapy regimen (regime/therapy)Regime/therapy
59201000210107Head and neck squamous cell metastatic - pembrolizumab triweekly flat dosing chemotherapy regimen (regime/therapy)Regime/therapy
59351000210101Head and neck squamous cell metastatic carboplatin and paclitaxel chemotherapy regimen (regime/therapy)Regime/therapy
59371000210109Head and neck squamous cell metastatic carboplatin, fluorouracil and pembrolizumab chemotherapy regimen (regime/therapy)Regime/therapy
59341000210104Head and neck squamous cell metastatic cisplatin and fluorouracil chemotherapy regimen (regime/therapy)Regime/therapy
59421000210103Head and neck squamous cell metastatic cisplatin, fluorouracil and pembrolizumab chemotherapy regimen (regime/therapy)Regime/therapy
59411000210108Head and neck squamous cell metastatic nivolumab biweekly flat dosing chemotherapy regimen (regime/therapy)Regime/therapy
59251000210108Head and neck squamous cell metastatic nivolumab every four weeks flat dosing chemotherapy regimen (regime/therapy)Regime/therapy
59221000210104Head and neck squamous cell metastatic nivolumab weight-based dosing chemotherapy regimen (regime/therapy)Regime/therapy
59401000210106Head and neck squamous cell metastatic paclitaxel weekly chemotherapy regimen (regime/therapy)Regime/therapy
59211000210109Head and neck squamous cell metastatic pembrolizumab every six weeks flat dosing chemotherapy regimen (regime/therapy)Regime/therapy
59391000210108Head and neck squamous cell metastatic pembrolizumab triweekly weight based dosing chemotherapy regimen (regime/therapy)Regime/therapy
59231000210102Head and neck squamous cell non-metastatic carboplatin and fluorouracil chemoradiation (regime/therapy)Regime/therapy
59451000210107Head and neck squamous cell non-metastatic cisplatin triweekly chemoradiation (regime/therapy)Regime/therapy
59321000210105Head and neck squamous cell non-metastatic cisplatin weekly chemoradition (regime/therapy)Regime/therapy
59241000210105Head and neck squamous cell non-metastatic cisplatin weekly post-operative chemoradiation (regime/therapy)Regime/therapy
201601000210109Hepatitis type B immunization program (regime/therapy)Regime/therapy
211631000210102Human papillomavirus immunization program (regime/therapy)Regime/therapy
211591000210102Immunization program (regime/therapy)Regime/therapy
211641000210105Meningococcal B immunization program (regime/therapy)Regime/therapy
211611000210109New Zealand national immunization program (regime/therapy)Regime/therapy
201611000210106Pneumococcal immunization program (regime/therapy)Regime/therapy
59281000210103Respiratory non small cell lung cancer metastatic cisplatin and gemcitabine chemotherapy regimen (regime/therapy)Regime/therapy
59291000210101Respiratory non small cell lung cancer non-metastatic cisplatin and gemcitabine chemoradiation (regime/therapy)Regime/therapy
59271000210100Respiratory non small cell lung cancer non-metastatic cisplatin and vinblastine chemoradiation (regime/therapy)Regime/therapy
211651000210108Severe acute respiratory syndrome coronavirus 2 immunization program (regime/therapy)Regime/therapy
211621000210104Tuberculosis immunization program (regime/therapy)Regime/therapy
59111000210102Upper gastrointestinal gastric and oesophageal metastatic docetaxel chemotherapy regimen (regime/therapy)Regime/therapy
59071000210107Upper gastrointestinal pancreas metastatic oxaliplatin, irinotecan, folinic acid and fluorouracil low dose folinic acid chemotherapy regimen (regime/therapy)Regime/therapy
57731000210103Upper gastrointestinal pancreas non-metastatic modified oxaliplatin, irinotecan, folinic acid and fluorouracil low dose folinic acid chemotherapy regimen (regime/therapy)Regime/therapy
59081000210109Upper gastrointestinal pancreas non-metastatic modififed oxaliplatin, irinotecan, folinic acid and fluorouracil high dose folinic acid chemotherapy regimen (regime/therapy)Regime/therapy
59091000210106Upper gastrointestinal pancreas non-metastatic oxaliplatin, irinotecan, folinic acid and fluorouracil high dose folinic acid chemotherapy regimen (regime/therapy)Regime/therapy
59101000210104Upper gastrointestinal pancreas non-metastatic oxaliplatin, irinotecan, folinic acid and fluorouracil low dose folinic acid chemotherapy regimen (regime/therapy)Regime/therapy
59261000210106Urogenital prostate metastatic zoledronic acid every six weeks chemotherapy regimen (regime/therapy)Regime/therapy
201581000210101Alternate vaccination given (situation)Situation
191811000210105Anticonvulsant prophylaxis to be done (situation)Situation
191841000210106Cytomegalovirus infection monitoring recommended (situation)Situation
191871000210101Folinic acid rescue therapy to be done (situation)Situation
191821000210100Graft-versus-host disease prophylaxis to be done (situation)Situation
191701000210103Hepatitis B virus prophylaxis recommended (situation)Situation
191741000210100Hepatitis B virus prophylaxis to be done (situation)Situation
191881000210104Hepatitis B virus prophylaxis under consideration (situation)Situation
191751000210102Herpesvirus infection prophylaxis recommended (situation)Situation
191711000210101Herpesvirus infection prophylaxis to be done (situation)Situation
191891000210102Herpesvirus infection prophylaxis under consideration (situation)Situation
201571000210103History of vaccination given in another country (situation)Situation
161811000210107Privately funded vaccination given (situation)Situation
191961000210102Proton pump inhibitor therapy recommended (situation)Situation
191971000210108Proton pump inhibitor therapy to be done (situation)Situation
191951000210100Proton pump inhibitor therapy under consideration (situation)Situation
161641000210109Publicly funded vaccination given due to medical condition included in criteria list (situation)Situation
161631000210101 Publicly funded vaccination given due to pregnancy (situation)Situation
161651000210107Publicly funded vaccination given for 65 years of age or older (situation)Situation
161801000210105Publicly funded vaccination given for child four years of age or under due to history of hospitalization with respiratory condition (situation)Situation
161791000210106Publicly funded vaccination given to Māori and Pacific people aged 55 to 64 years of age (situation)Situation
181661000210107Suspected malignancy - high (situation)Situation
181671000210101Suspected malignancy - low (situation)Situation
181681000210104Suspected malignancy - not stated (situation)Situation
191911000210104Thrombosis prophylaxis recommended (situation)Situation
191931000210106Thrombosis prophylaxis to be done (situation)Situation
191921000210109Thrombosis prophylaxis under consideration (situation)Situation
191761000210104Tumor lysis syndrome prophylaxis (procedure)Situation
191901000210101Tumor lysis syndrome prophylaxis recommended (situation)Situation
191801000210108Tumor lysis syndrome prophylaxis to be done (situation)Situation
191791000210109Tumor lysis syndrome prophylaxis under consideration (situation)Situation
191851000210109Veno-occlusive disease of the liver prophylaxis (procedure)Situation
191861000210107Veno-occlusive disease of the liver prophylaxis recommended (situation)Situation
191941000210103Veno-occlusive disease of the liver prophylaxis under consideration (situation)Situation
211701000210101Cord blood stem cell donor (person)Person
211661000210106Matched related stem cell donor (person)Person
211671000210100Matched unrelated stem cell donor (person)Person
211681000210103Mismatched related stem cell donor (person)Person
211691000210101Mismatched unrelated stem cell donor (person)Person


Table 3.1 Reference sets in the SNOMED CT NZ Extension October 2022 release

SNOMED CT Concept ID

(SCTID)

SNOMED CT Fully Specified Name (FSN)

Members

351000210106

New Zealand adverse reaction manifestation reference set (foundation metadata concept)

1886

72671000210109New Zealand alcohol consumption reference set (foundation metadata concept)3

421000210109

New Zealand ambulance clinical impression reference set (foundation metadata concept)

176

61241000210100New Zealand biological substance common allergen reference set (foundation metadata concept)207

91000210107

New Zealand cardiology reference set (foundation metadata concept)

63

61251000210102New Zealand chemical substance common allergen reference set (foundation metadata concept)623

191000210102

New Zealand child developmental services reference set (foundation metadata concept)

137

241000210102

New Zealand child health assessment reference set (foundation metadata concept)

186

471000210108

New Zealand clinical specialty reference set (foundation metadata concept)

157

61271000210105New Zealand common pharmaceutical dose form reference set (foundation metadata concept)12
61281000210107New Zealand common pharmaceutical dose frequency reference set (foundation metadata concept)12
61291000210109New Zealand common pharmaceutical dose unit reference set (foundation metadata concept)11
61231000210108New Zealand COVID-19 adverse event from immunization reference set (foundation metadata concept)58

261000210101

New Zealand disability reference set (foundation metadata concept)

96

61261000210104New Zealand edible substance common allergen reference set (foundation metadata concept)419

61000210102

New Zealand emergency care diagnosis reference set (foundation metadata concept)

1467

71000210108

New Zealand emergency care presenting complaint reference set (foundation metadata concept)

158

321000210102

New Zealand emergency care procedure reference set (foundation metadata concept)

74

141000210106

New Zealand endocrinology reference set (foundation metadata concept)

263

181000210104

New Zealand general paediatric reference set (foundation metadata concept)

441

131000210103

New Zealand general surgery reference set (foundation metadata concept)

97

101000210108

New Zealand gynaecology reference set (foundation metadata concept)

143

451000210100

New Zealand health occupation reference set (foundation metadata concept)

87

461000210102

New Zealand health service type reference set (foundation metadata concept)

228

501000210102

New Zealand laboratory order reference set (foundation metadata concept)

956

72621000210105New Zealand maternity Apgar score reference set (foundation metadata concept)33
72631000210107New Zealand maternity complementary therapies reference set (foundation metadata concept)17

72601000210102

New Zealand maternity complications reference set (foundation metadata concept)

32

72611000210100

New Zealand maternity disorders reference set (foundation metadata concept)

44

72661000210103

New Zealand maternity family history reference set (foundation metadata concept)

12

72591000210107

New Zealand maternity findings reference set (foundation metadata concept)

156

72581000210105

New Zealand maternity mode of delivery reference set (foundation metadata concept)

4

72571000210108

New Zealand maternity outcomes reference set (foundation metadata concept)

8

72541000210103

New Zealand maternity previous complications reference set (foundation metadata concept)

47

72551000210100

New Zealand maternity previous disorders reference set (foundation metadata concept)

63

72531000210106

New Zealand maternity previous findings reference set (foundation metadata concept)

49

72521000210109

New Zealand maternity previous mode of delivery reference set (foundation metadata concept)

4

72511000210104

New Zealand maternity previous outcomes reference set (foundation metadata concept)

9

72501000210101

New Zealand maternity previous procedures reference set (foundation metadata concept)

23

72561000210102

New Zealand maternity procedures reference set (foundation metadata concept)

51

72641000210104

New Zealand maternity screening and tests reference set (foundation metadata concept)

21

72651000210101

New Zealand maternity substances reference set (foundation metadata concept)

13

391000210104

New Zealand microorganism reference set (foundation metadata concept)

18710

50931000210104New Zealand nephrology reference set (foundation metadata)99

72691000210108

New Zealand non-medicinal drug reference set (foundation metadata concept)

16

72681000210106

New Zealand non-medicinal drug use reference set (foundation metadata concept)

6

251000210104

New Zealand notifiable disease reference set (foundation metadata concept)

97

50941000210107New Zealand ophthalmology reference set (foundation metadata concept)64
121531000210107

New Zealand radiology procedures reference set (foundation metadata concept)

914

121000210100

New Zealand rheumatology reference set (foundation metadata concept)

126

192071000210103New Zealand referral status reference set (foundation metadata concept)7
121521000210105New Zealand severe acute respiratory syndrome coronavirus 2 symptoms reference set (foundation metadata concept)19

481000210105

New Zealand site of care reference set (foundation metadata concept)

8

72731000210103New Zealand smoking intervention reference set (foundation metadata concept)5
72741000210106New Zealand smoking status reference set (foundation metadata concept)4

441000210103

New Zealand surgical complication reference set (foundation metadata concept)

147

192091000210104New Zealand suspicion of cancer reference set (foundation metadata concept)4
192081000210101New Zealand priority score reference set (foundation metadata concept)7
72721000210100New Zealand vaping status reference set (foundation metadata concept)7



Approvals


Final Version

Date

Approver

Comments

0.2

Lea MiharsaApproved
1.0

Alastair KenworthyApproved



Download .pdf here:






Draft Amendment History


Version

Date

Editor

Comments

0.1

 

Andrew AtkinsonInitial draft created
1.0

Lea MiharsaFinal version
  • No labels